Abaloparatide (Tymlos) studies: 157 papers with results
Page 3 of 4
- Local injection of abaloparatide promotes mandibular condyle lengthening in adolescent rats via enhancing chondrogenesis and ossification.
Xu L · Journal of oral rehabilitation · 2024
Animal study (in vivo) · rat · 13 results
- The effects of abaloparatide on alveolar bone loss in postmenopausal osteoporotic rats with periodontitis.
Kızıldağ A · BMC oral health · 2025
Animal study (in vivo) · rat · 12 results
- Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model.
Abe T · International journal of molecular sciences · 2024
Animal study (in vivo) · rat · 13 results
- Differential effects of parathyroid hormone, parathyroid hormone-related protein, and abaloparatide on collagen 1 expression by mouse cementoblasts and mouse tooth root density.
Hsu C · American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics · 2023
Animal study (in vivo) · mouse · 4 results
- DMP1-Cre expressing cells mediate the gain in bone mass and strength, but not the increase in bone remodeling, induced by ligands of the parathyroid hormone receptor.
Akel N · Bone research · 2026
Animal study (in vivo) · mouse · 16 results
- Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancer.
Miller JS · Journal of bone oncology · 2026
Animal study (in vivo) · 4 results
- Abaloparatide-Zoledronate combination protects against 4-vinylcyclohexene diepoxide-induced postmenopausal osteoporosis in mice: an osteoanabolic-antiresorptive approach.
Ara T · Naunyn-Schmiedeberg's archives of pharmacology · 2026
Animal study (in vivo) · mouse · 5 results
- Abaloparatide increases bone mass by increasing bone formation regardless of alendronate pretreatment in mice.
Makino A · Journal of oral biosciences · 2026
Animal study (in vivo) · mouse · 4 results
- Histochemical assessment of the anabolic effects of abaloparatide on the femoral metaphyses of ovariectomized mice.
Liu X · Journal of oral biosciences · 2025
Animal study (in vivo) · mouse · 8 results
- Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1-34).
Le Henaff C · JBMR plus · 2023
Animal study (in vivo) · mouse · 15 results
- Sex-Specific Differences in Gsα-Mediated Signaling Downstream of PTH1R Activation by Abaloparatide in Bone.
Swami S · JBMR plus · 2022
Animal study (in vivo) · mouse · 2 results
- 302 Abaloparatide as a novel therapy for posttraumatic osteoarthritis
Landgrave S · Journal of clinical and translational science
Animal study (in vivo) · mouse · 5 results
- Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling.
Hattersley G · Endocrinology · 2016
In vitro (cells) · 2 results
- Precisely Controlled Delivery of Abaloparatide through Injectable Hydrogel to Promote Bone Regeneration.
Ning Z · Macromolecular bioscience · 2019
In vitro (cells) · 4 results
- Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTH.
Sato T · JBMR plus · 2021
In vitro (cells) · 16 results
- Effect of the PTHrP(1-34) analog abaloparatide on inducing chondrogenesis involves inhibition of intracellular reactive oxygen species production.
Yang Y · Biochemical and biophysical research communications · 2019
In vitro (cells) · mouse · 2 results
- Differential Effects of PTH (1-34), PTHrP (1-36), and Abaloparatide on the Murine Osteoblast Transcriptome.
Mosca MJ · Journal of the Endocrine Society · 2023
In vitro (cells) · mouse · 6 results
- Parathyroid Hormone-Related Peptide and Its Analog, Abaloparatide, Attenuate Lethal Myocardial Ischemia-Reperfusion Injury.
Wider J · Journal of clinical medicine · 2022
In vitro (cells) · 4 results
- OR21-4 Comparison of the Effects of PTH (1-34), PTHrP (1-36) and Abaloparatide (ABL) on the Murine Osteoblast Transcriptome
Journal of the Endocrine Society · 2022
In vitro (cells) · mouse · 7 results
- SAT-402 Investigating Analogues of Parathyroid Hormone (PTH) and PTH-Related Peptide (PTHrP) to Improve Anabolic: Catabolic Response Ratios Using UMR106-01 Osteocytic Cells
Oladapo O · Journal of the Endocrine Society · 2020
In vitro (cells) · 1 result
- Molecular insights into peptide agonist engagement with the PTH receptor.
Cary BP · Structure (London, England : 1993) · 2023
In vitro (cell-free) · 4 results
- Osteoclast Precursor Membrane-Coated Nanoparticles Loaded With Abaloparatide Enable Dual Modulation of Osteoclast and Osteoblast Differentiation.
Fu M · Applied biochemistry and biotechnology · 2026
Not a test of Abaloparatide (Tymlos) alone · 14 results
- Timeliness of antiresorptive consolidation after anabolic therapy for primary fracture prevention: A US cohort study.
Badour S · The Journal of clinical endocrinology and metabolism · 2026
Not a test of Abaloparatide (Tymlos) alone · 13 results
- Zinc finger-inspired peptide-metal-phenolic nanointerface enhances bone-implant integration under bacterial infection microenvironment through immune modulation and osteogenesis promotion.
Xu L · Bioactive materials · 2024
Not a test of Abaloparatide (Tymlos) alone · 11 results
- Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1-34) analogs in women.
Lu KH · Biology of sex differences · 2026
Not a test of Abaloparatide (Tymlos) alone · 8 results
- Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003-2021.
Wadhwa H · JBMR plus · 2023
Not a test of Abaloparatide (Tymlos) alone · 7 results
- Cost-effectiveness of radiofrequency echographic multi-spectrometry for the diagnosis of osteoporosis in the United States.
Reginster JY · JBMR plus · 2025
Not a test of Abaloparatide (Tymlos) alone · 7 results
- Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis.
Imel EA · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
Not a test of Abaloparatide (Tymlos) alone · 13 results
- A dual-active biological scaffold with in situ loaded Abaloparatide and bone marrow-derived mesenchymal stem cells synergistically regulatory T cell to promote bone regeneration.
Jia M · Biomaterials advances · 2026
Not a test of Abaloparatide (Tymlos) alone · 7 results
- A thorough LC-MS/MS strategy to quantify abaloparatide in rat plasma: method development, validation and application.
Kong Y · Analytical methods : advancing methods and applications · 2025
Not a test of Abaloparatide (Tymlos) alone · 7 results
- Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States.
Le QA · The Annals of pharmacotherapy · 2019
Not a test of Abaloparatide (Tymlos) alone · 8 results
- Cardiovascular Outcomes Following Therapeutic Sclerostin Inhibition Compared With Alternative Anabolic Therapies: A Real-World Propensity Score-Matched Analysis.
Barnett MJL · Journal of osteoporosis · 2026
Not a test of Abaloparatide (Tymlos) alone · 6 results
- Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures.
Hiligsmann M · Aging clinical and experimental research · 2024
Not a test of Abaloparatide (Tymlos) alone · 5 results
- Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States.
Hiligsmann M · PharmacoEconomics · 2023
Not a test of Abaloparatide (Tymlos) alone · 5 results
- Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation.
January SE · Pharmacotherapy · 2025
Not a test of Abaloparatide (Tymlos) alone · 5 results
- Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture.
Hiligsmann M · Seminars in arthritis and rheumatism · 2019
Not a test of Abaloparatide (Tymlos) alone · 7 results
- USP7 regulates the proliferation and differentiation of ATDC5 cells through the Sox9-PTHrP-PTH1R axis.
Dong X · Bone · 2021
Not a test of Abaloparatide (Tymlos) alone · 4 results
- Electrospun nanofibers containing chitosan-stabilized bovine serum albumin nanoparticles for bone regeneration.
Lin P · Colloids and surfaces. B, Biointerfaces · 2022
Not a test of Abaloparatide (Tymlos) alone · 4 results
- Cost-Effectiveness of Opportunistic Osteoporosis Screening Using Chest Radiographs With Deep Learning in the United States.
Hiligsmann M · Journal of the American College of Radiology : JACR · 2025
Not a test of Abaloparatide (Tymlos) alone · 4 results
- Biodegradable Nanoflowers with Abaloparatide Spatiotemporal Management of Functional Alveolar Bone Regeneration.
Tan B · Nano letters · 2024
Not a test of Abaloparatide (Tymlos) alone · 4 results
- Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatide.
Cosman F · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
Not a test of Abaloparatide (Tymlos) alone · 6 results
- Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation.
Zhai X · Nature communications · 2022
Not a test of Abaloparatide (Tymlos) alone · 3 results
- Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective.
Hiligsmann M · Seminars in arthritis and rheumatism · 2020
Not a test of Abaloparatide (Tymlos) alone · 3 results
- Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries.
Sendhil SR · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
Not a test of Abaloparatide (Tymlos) alone · 3 results
- Cost-effectiveness analysis of five drugs for treating postmenopausal women in the United States with osteoporosis and a very high fracture risk.
Luo C · Journal of endocrinological investigation · 2023
Not a test of Abaloparatide (Tymlos) alone · 2 results
- Treatment of Osteoporosis With Anabolic Agents and the Risk of Primary Bone Cancers: A Study of 44,728 Patients Treated With Teriparatide and Abaloparatide.
McDonald CL · The Journal of the American Academy of Orthopaedic Surgeons · 2023
Not a test of Abaloparatide (Tymlos) alone · 4 results
- A bone optimization rheumatology clinic increases anabolic bone agent use and reduces mechanical complications in adult spinal deformity surgery.
Jain H · Spine deformity · 2026
Not a test of Abaloparatide (Tymlos) alone · 2 results
- Effect of the COVID-19 Pandemic on Treatment Strategies for Secondary Prevention of Hip Fragility Fractures.
Mazza O · The Israel Medical Association journal : IMAJ · 2026
Not a test of Abaloparatide (Tymlos) alone · 2 results
- Risk of medication-related osteonecrosis of the jaw during romosozumab treatment.
Stokar J · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
Not a test of Abaloparatide (Tymlos) alone · 2 results
- Micro/nanoparticle hybrid hydrogel platform with mild photothermal stimulation on abaloparatide in situ release for cranial bone regeneration.
Wu Y · Journal of materials chemistry. B · 2026
Not a test of Abaloparatide (Tymlos) alone · 2 results